Skip to the page

Data / Drug companies / Echinocandin Antifungal

Echinocandin Antifungal drugs: 6 drugs from 18 companies in the FDA NDC directory

Echinocandin Antifungal is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 42 products in this class from 18 companies, covering 6 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on April 1, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 18Companies
  • 42Products
  • 6Drugs by generic name

Drugs in the Echinocandin Antifungal class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Caspofungin acetate147
Micafungin126
Micafungin sodium94
Anidulafungin31
Micafungin in sodium chloride31
Rezafungin11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Fresenius Kabi USA, LLC5injection, powder, lyophilized, for solutionGeneric drugs (ANDA)May 8, 2020
Sagent Pharmaceuticals4injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 15, 2023
Baxter Healthcare Corporation3injectionNew drug applications (NDA)September 29, 2023
Roerig3injection, powder, lyophilized, for solutionNew drug applications (NDA)February 20, 2024
Biocon Pharma Inc.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)June 1, 2025
Fosun Pharma USA Inc.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 2, 2019
Gland Pharma Limited2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)October 29, 2017
Glenmark Pharmaceuticals Inc., USA2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)June 30, 2025
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)October 8, 2025
Hikma Pharmaceuticals USA Inc.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 9, 2021
Hisun Pharmaceuticals USA, Inc.2injection, powder, for solutionGeneric drugs (ANDA)April 1, 2026
Meitheal Pharmaceuticals Inc.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 28, 2022
Merck Sharp & Dohme LLC2injection, powder, lyophilized, for solutionNew drug applications (NDA)January 26, 2001
Qilu Pharmaceutical Co., Ltd.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 3, 2025
Sandoz Inc2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 4, 2018
Zydus Lifesciences Limited2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 10, 2023
Zydus Pharmaceuticals USA Inc.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 10, 2023
Melinta Therapeutics, LLC1injection, powder, lyophilized, for solutionNew drug applications (NDA)June 9, 2023

Dosage forms

Dosage formProductsShare
Injection, powder, lyophilized, for solution3788.1%
Injection37.1%
Injection, powder, for solution24.8%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.